PCF Leadership

• Gina B. Carithers, President
• Howard R. Soule, PhD, Chief Science Officer and Executive Vice President
• Stuart Holden, MD, Medical Director
• Andrea Miyahira, PhD, Senior Director, Global Research & Scientific Communications
• Development & Translation Committee, PCF Board of Directors

Surgical Urologic Oncology

• William Aronson, MD, University of California, Los Angeles
• Neil Bander, MD, Weill Cornell Medicine
• Christopher Barbieri, MD, PhD, Weill Cornell Medicine
• Wayne Brisbane, MD, University of California, Los Angeles
• Brett Carver, MD, Memorial Sloan Kettering Cancer Center
• Harveer Dev, MD, PhD, University of Cambridge
• Renu Eapen, MBBS, FRACS, Peter MacCallum Cancer Centre
• Adam Feldman, MD, Harvard: Massachusetts General Hospital
• Stephen Freedland, MD, Cedars Sinai Medical Center
• Isla Garraway, MD, PhD, University of California, Los Angeles
• Jeffrey Jones, MD, Michael E. DeBakey VA Medical Center
• Rakesh Heer, MBBS, PhD, Newcastle University
• Mayuko Kanayama, MD, PhD, Johns Hopkins University
• Hing Leung, MBBS, PhD, University of Glasgow – Cancer Research UK Beatson Institute
• Stacy Loeb, MD, New York University
• Danil Makarov, MD, New York University
• Todd Morgan, MD, University of Michigan
• Hao Nguyen, MD, PhD, University of California, San Francisco
• Mark Preston, MD, MPH, University of California, San Diego
• Ganesh Raj, MD, PhD, University of Texas Southwestern
• Robert Reiter, MD, University of California, Los Angeles
• Michael Rothberg, MD, National Cancer Institute
• Ashwin Sachdeva, MBBS, PhD, University of Manchester
• Simpa Salami, MD, University of Michigan
• Martin Sanda, MD, Emory University
• Udit Singhal, MD, University of Michigan
• Vasilis Stavrinides, MD, PhD, University College London
• Jeffrey Tosoian, MD, Vanderbilt University
• Quoc-Dien Trinh, MD, Harvard: Brigham and Women’s Hospital

Medical Oncology and Treatment Sciences

• Rahul Aggarwal, MD, University of California, San Francisco
• Joshi Alumkal, MD, University of Michigan
• Emmanuel Antonarakis, MD, University of Minnesota
• Ana Aparicio, MD, The University of Texas MD Anderson Cancer Center
• Andrew Armstrong, MD, Duke University
• Mohammad Atiq, MD, National Institutes of Health
• Gerhardt Attard, MD, PhD, University College London
• Himisha Beltran, MD, Harvard: Dana-Farber Cancer Institute
• Hala Borno, MD, University of California San Francisco
• Rohit Bose, MD, PhD, University of California San Francisco
• Frank Cackowski, MD, PhD, Wayne State University
• Megan Caram, MD, University of Michigan
• Maria Carlo, MD, Memorial Sloan Kettering Cancer Center
• Elena Castro, MD, PhD, Spanish National Cancer Research Centre
• Heather Cheng, MD, PhD, University of Washington
• Michael Cheng, MD, University of California San Francisco
• Atish Choudhury, MD, PhD, Harvard: Dana-Farber Cancer Institute
• Suzanne Conzen, MD, University of Texas Southwestern
• Johannes Czernin, MD, University of California, Los Angeles
• Tanya Dorff, MD, City of Hope
• William Dahut, MD, American Cancer Society
• Johann de Bono, MD, PhD, Institute of Cancer Research, Royal Marsden Hospital
• David Einstein, MD, Harvard: Beth Israel Deaconess Medical Center
• Ivan de Kouchkovsky, MD, University of California San Francisco
• Samuel Denmeade, MD, Johns Hopkins University
• Matthew Freedman, MD, Harvard: Dana-Farber Cancer Institute
• Terence Friedlander, MD, University of California, San Francisco
• Daniel George, MD, Duke University
• Jun Gong, MD, Cedars-Sinai Medical Center
• Emily Grist, MBBS, University College London Cancer Institute
• Andrew Hahn, MD, The University of Texas MD Anderson Cancer Center
• Anis Hamid, MBBS, University of Melbourne
• Jessica Hawley, MD, University of Washington
• Elisabeth Heath, MD, Wayne State University
• Andrew Hsieh, MD, Fred Hutchinson Cancer Research Center
• Maha Hussain, MD, Northwestern University
• Anthony Michael Joshua, MD, PhD, Kinghorn Cancer Centre
• Philip Kantoff, MD, Memorial Sloan Kettering Cancer Center
• William K. Kelly, DO, Thomas Jefferson University
• Vadim Koshkin, MD, University of California, San Francisco
• Edmond Kwan, MBBS, PhD, Vancouver Prostate Centre
• Christos Kyriakopoulos, MD, University of Wisconsin
• Andrew Laccetti, MD, Memorial Sloan Kettering Cancer Center
• Joshua Lang, MD, University of Wisconsin
• Richard Lee, MD, PhD, Harvard: Massachusetts General Hospital
• Christopher Logothetis, MD, The University of Texas MD Anderson Cancer Center
• Mark Markowski, MD, PhD, Johns Hopkins University
• Catherine Marshall, MD, Johns Hopkins University
• Joaquin Mateo, MD, PhD, Vall d’Hebron Institute of Oncology
• Kara Maxwell, MD, PhD, University of Pennsylvania (Corporal Michael J. Crescenz VA Medical Center)
• Nicholas Mitsiades, MD, PhD, Baylor College of Medicine
• Alicia Morgans, MD, MPH, Harvard: Dana-Farber Cancer Institute
• Michael Morris, MD, Memorial Sloan Kettering Cancer Center
• Elahe Mostaghel, MD, PhD, Fred Hutchinson Cancer Research Center
• Vivek Narayan, MD, University of Pennsylvania
• Peter Nelson, MD, Fred Hutchinson Cancer Research Center
• William Nelson, MD, PhD, Johns Hopkins University
• David Oh, MD, PhD, University of California, San Francisco
• Jacob Orme, MD, PhD, Mayo Clinic
• Ravi Parikh, MD, University of Pennsylvania (Corporal Michael J. Crescenz VA Medical Center)
• Alec Paschalis, MBBS, Institute of Cancer Research
• Kenneth Pienta, MD, Johns Hopkins University
• Roberto Pili, MD, Roswell Park Cancer Institute
• Mark Pomerantz, MD, Harvard: Dana-Farber Cancer Institute
• Edwin Posadas, MD, Cedars-Sinai Medical Center
• Dana Rathkopf, MD, Memorial Sloan Kettering Cancer Center
• Praful Ravi, MD, Harvard: Dana-Farber Cancer Institute
• Pasquale Rescigno, MD, Candiolo Institute of Cancer Research
• Matthew Rettig, MD, University of California, Los Angeles
• Joshua Russo, MD, PhD, Harvard: Beth Israel Deaconess Medical Center
• Oliver Sartor, MD, Tulane University
• Philip Saylor, MD, Harvard: Massachusetts General Hospital
• Howard Scher, MD, Memorial Sloan Kettering Cancer Center
• Martin Schoen, MD, MPH, Saint Louis Veterans Affairs Medical Center
• Laura Sena, MD, PhD, Johns Hopkins University
• Marina Sharifi, MD, PhD, University of Wisconsin
• Nima Sharifi, MD, Cleveland Clinic
• Adam Sharp, MD, PhD, Institute of Cancer Research, Royal Marsden Hospital
• Bilal Siddiqui, MD, The University of Texas MD Anderson Cancer Center
• Martin Sjöström, MD, PhD, University of California, San Francisco
• Eric Small, MD, University of California, San Francisco
• Matthew Smith, MD, PhD, Harvard: Massachusetts General Hospital
• Walter Stadler, MD, University of Chicago
• Christopher Sweeney, MBBS, Harvard: Dana-Farber Cancer Institute
• Scott Tagawa, MD, Weill Cornell Medicine
• David Takeda, MD, PhD, National Cancer Institute
  
• Mary-Ellen Taplin, MD, Harvard: Dana-Farber Cancer Institute
• Alok Tewari, MD, PhD, Harvard: Dana-Farber Cancer Institute
• Eliezer Van Allen, MD, Harvard: Dana-Farber Cancer Institute
• David VanderWeele, MD, PhD, Northwestern University
• Srinivas Viswanathan, MD, PhD, Harvard: Dana-Farber Cancer Institute
• Evan Yu, MD, University of Washington
• David Wise, MD, PhD, New York University
• Samir Zaidi, MD, PhD, Memorial Sloan Kettering Cancer Center
• Xiaolin Zhu, MD, PhD, University of California, San Francisco

Immunotherapy

• Nathaniel Brennen, PhD, Johns Hopkins University
• George Coukos, MD, PhD, University of Lausanne
• Charles Drake, MD, PhD, Columbia University
• Lawrence Fong, MD, University of California, San Francisco
• Stephen Forman, MD, City of Hope
• Julie Graff, MD, VA Portland Health Care System
• James Gulley, MD, PhD, National Cancer Institute
• Fatima Karzai, MD, National Cancer Institute
• Haydn Kissick, PhD, Emory University
• Marcin Kortylewski, PhD, City of Hope
• Benjamin Larman, PhD, Johns Hopkins University
• Ravi Madan, MD, National Cancer Institute
• Douglas McNeel, MD, PhD, University of Wisconsin
• Amy Moran, PhD, Oregon Health & Science University
• John Murad, PhD, City of Hope
• Paul Nghiem, MD, PhD, University of Washington
• Brian Olson, PhD, University of Chicago
• Russell Pachynski, MD, Washington University
• Eileen Parkes, MD, PhD, University of Oxford
• Saul Priceman, PhD, City of Hope
• William Redmond, PhD, Providence Portland Medical Center
• David Sanin, PhD, Johns Hopkins University
• Jinjun Shi, PhD, Harvard: Brigham and Women’s Hospital
• Sumit Subudhi, MD, PhD, The University of Texas, MD Anderson Cancer Center
• Jennifer Wu, PhD, Northwestern University
• Jelani Zarif, PhD, Johns Hopkins University
• Nicholas Zorko, MD, PhD, University of Minnesota

Genomics / Bioinformatics

• Saud AlDubayan, MD, Harvard: Dana-Farber Cancer Institute
• Juan Arriaga, PhD, Icahn School of Medicine at Mount Sinai Hospital
• Paul Boutros, PhD, MBA, University of California, Los Angeles
• Marcin Cieslik, PhD, University of Michigan
• Francesca Demichelis, PhD, Universita’ degli Studi di Trento
• Michael Evans, PhD, University of California, San Francisco
• Roni Haas, PhD, University of California, Los Angeles
• William Hahn, MD, PhD, Harvard: Dana-Farber Cancer Institute
• Hannelore Heemers, PhD, Cleveland Clinic
• Christopher Haiman, ScD, University of Southern California
• Franklin Huang, MD, PhD, University of California, San Francisco
• William Isaacs, PhD, Johns Hopkins University
• Jun Luo, PhD, Johns Hopkins University
• Christopher Maher, PhD, Washington University
• Antonina Mitrofanova, PhD, Rutgers Cancer Institute of New Jersey
• Yashar Niknafs, PhD, University of Michigan
• Colin Pritchard, MD, PhD, University of Washington
• David Quigley, PhD, University of California, San Francisco
• Keyan Salari, MD, PhD, Harvard: Massachusetts General Hospital
• Nikolaus Schultz, PhD, Memorial Sloan Kettering Cancer Center
• Woogwang Sim, PhD, University of California, San Francisco
• Alexandra Sokolova, MD, Oregon Health & Science University
• Elizabeth Wasmuth, PhD, University of Texas Health Science Center at San Antonio
• Alexander Wyatt, PhD, Vancouver Prostate Centre

Basic Science

• Cory Abate-Shen, PhD, Columbia University
• Sarki Abdulkadir, MD, PhD, Northwestern University
• Dario Altieri, MD, Wistar Institute
• Sarah Amend, PhD, Johns Hopkins University
• Irfan Asangani, PhD, University of Pennsylvania
• Mohammad Asim, PhD, University of Surrey
• Steven Balk, MD, PhD, Harvard: Beth Israel Deaconess Medical Center
• Vipul Bhatia, PhD, Fred Hutchinson Cancer Research Center
• Charles Bieberich, PhD, University of Maryland
• Chad Brenner, PhD, University of Michigan
• George Butler, PhD, Johns Hopkins University
• Qi Cao, PhD, The Methodist Hospital Research Institute
• Hongwu Chen, PhD, University of California, Davis
• Yu Chen, MD, PhD, Memorial Sloan Kettering Cancer Center
• Lisa Chesner, PhD, University of California, San Francisco
• Jonathan Chou, MD, PhD, University of California, San Francisco
• Scott Dehm, PhD, University of Minnesota
• Christina Dieli-Conwright, PhD, MPH, Harvard: Dana-Farber Cancer Institute
• Eleonora Dondossola, PhD, The University of Texas MD Anderson Cancer Center
• Dimitrios Doultsinos, PhD, University of Oxford
• Asmaa Elkenawi, PhD, H. Lee Moffitt Cancer Center & Research Institute
• Leigh Ellis, PhD, Cedars Sinai Medical Center
• Claire Fletcher, PhD, Imperial College London
• Nicolette Fonseca, PhD, University of British Columbia
• Luke Gilbert, PhD, University of California, San Francisco
• Andrew Goldstein, MD, University of California, Los Angeles
• David Goodrich, PhD, Roswell Park Cancer Institute
• Rebecca Graff, ScD, University of California, San Francisco
• Geraldine Gueron, PhD, Iquibicen-Conicet
• Amanda Hargrove, PhD, Duke University
• Christopher Heaphy, PhD, Boston University
• Anastasia Hepburn, PhD, Newcastle University
• Haojie Huang, PhD, Mayo Clinic
• John Isaacs, PhD, Johns Hopkins University
• Christina Jamieson, PhD, University of California, San Diego
• Dong-Woo Kang, PhD, Harvard: Dana-Farber Cancer Institute
• Kalpana Kannan, PhD, Baylor College of Medicine
• Salma Kaochar, PhD, Baylor College of Medicine
• Wouter Karthous, PhD, Memorial Sloan Kettering Cancer Center
• Steven Kregel, PhD, Loyola University Chicago
• Anson Ku, PhD, National Institutes of Health
• Sheng-Yu Ku, PhD, Harvard: Dana-Farber Cancer Institute
• Rajan Kulkarni, MD, PhD, Oregon Health & Science University
  
• Rajendra Kumar, PhD, Johns Hopkins University
• Natasha Kyprianou, PhD, Icahn School of Medicine at Mount Sinai Hospital
• David Labbé, PhD, Harvard: Dana-Farber Cancer Institute
• Marikki Laiho, MD, PhD, Johns Hopkins University
• Hung-Ming Lam, PhD, University of Washington
• Lucia Languino, PhD, Thomas Jefferson University
• Aaron LeBeau, PhD, University of Wisconsin
• Haolong Li, PhD, University of California, San Francisco
• Hui Li, PhD, University of California, San Francisco
• Shyh-Dar Li, PhD, The University of British Columbia
• Weiping Li, PhD, Columbia University Medical Center
• Neil Lin, PhD, University of California, Los Angeles
• Shawn Lupold, PhD, Johns Hopkins University
• Everardo Macias, PhD, Duke University
• Nupam Mahajan, PhD, Washington University
• Alan Meeker, MD, PhD, Johns Hopkins University
• Nigel Mongan, PhD, University of Nottingham
• Ping Mu, PhD, University of Texas Southwestern
• David Mulholland, PhD, Icahn School of Medicine at Mount Sinai Hospital
• Lucia Nappi, MD, PhD, University of British Columbia
• Nora Navone, MD, PhD, The University of Texas MD Anderson Cancer Center
• Alexandros Papachristodoulou, PhD, Columbia University Medical Center
• Jung Wook Park, PhD, Duke University
• Abhijit Parolia, PhD, University of Michigan
• Ramon Parsons, MD, PhD, Icahn School of Medicine at Mount Sinai Hospital
• Steven Patierno, PhD, Duke University
• Sethuramasundaram Pitchiaya, PhD, University of Michigan
• Stephen Plymate, MD, University of Washington
• Sonam Raj, PhD, National Institutes of Health
• Veronica Rodriguez-Bravo, PhD, Mayo Clinic
• Anirban Sahu, MD, University of Michigan
• Jack Schalken, PhD, University Hospital of Nijmegen
• Matthew Schiewer, PhD, Thomas Jefferson University
• Luke Selth, PhD, University of Adelaide
• Karen Sfanos, PhD, Johns Hopkins University
• Ayesha Shafi, PhD, HJF – Henry Jackson Foundation for the Advancement of Military Medicine / Uniformed Services University
• Michael Shen, PhD, Columbia University
• Yusuke Shiozawa, MD, PhD, Wake Forest School of Medicine
• Raunak Shrestha, PhD, University of California, San Francisco
• Adam Sowalsky, PhD, National Cancer Institute
• William Storck, PhD, University of Michigan
• Tanya Stoyanova, PhD, Stanford University
• Timothy Thompson, PhD, The University of Texas MD Anderson Cancer Center
• Jean Tien, PhD, University of Michigan
• Anna Trigos, PhD, Peter MacCallum Cancer Centre
• Hung-Ji Tsai, PhD, Johns Hopkins University
• David Ulmert, MD, PhD, University of California, Los Angeles
• Scott Wilkinson, PhD, National Cancer Institute
• Shaomeng Wang, PhD, University of Michigan
• Yuzhuo Wang, PhD, BC Cancer Agency
• Alexander Wurzer, PhD, Technical University of Munich
• Lanbo Xiao, PhD, University of Michigan
• Li Xin, PhD, University of Washington
• Kexin Xu, PhD, University of Texas Health Science Center at San Antonio
• Srinivasan Yegnasubramanian, MD, PhD, Johns Hopkins University
• Young Yoo, PhD, Northwestern University
• Jindan Yu, MD, PhD, Emory University
• Di Zhao, PhD, The University of Texas MD Anderson Cancer Center
• Amina Zoubeidi, PhD, University of British Columbia

Radiation Oncology

• Robert Bristow, MD, PhD, Manchester Cancer Research Centre
• Adam Dicker, MD, PhD, Thomas Jefferson University
• Jason Efstathiou, MD, PhD, Harvard: Massachusetts General Hospital
• Felix Feng, MD, University of California, San Francisco
• Julian Hong, MD, University of California, San Francisco
• Sophia Kamran, MD, Harvard: Massachusetts General Hospital
• Ariel Marciscano, MD, Weill Cornell Medicine
• David Miyamoto, MD, PhD, Harvard: Massachusetts General Hospital
• Kent Mouw, MD, PhD, Harvard: Harvard: Dana-Farber Cancer Institute
• Paul Nguyen, MD, Harvard: Harvard: Dana-Farber Cancer Institute
• Nicholas Nickols, MD, PhD, University of California, Los Angeles
• Ryan Park, MD, Harvard: Massachusetts General Hospital
• Sagar Patel, MD, Emory University
• Zachery Reichert, MD, PhD, University of Michigan
• Tyler Seibert, MD, PhD, University of California, San Diego
• Daniel Spratt, MD, Case Western Reserve
• Shervin Tabrizi, MD, Harvard: Massachusetts General Hospital
• Phuoc Tran, MD, PhD, Johns Hopkins University
• Scott Williams, MD, Peter MacCallum Cancer Centre

Molecular Imaging (Radiology)

• Steve Cho, MD, University of Wisconsin
• Peter Choyke, MD, National Cancer Institute
• Jeremy Durack, MD, Memorial Sloan Kettering Cancer Center
• Robert Flavell, MD, PhD, University of California, San Francisco
• Francesco Giganti, MD, University College London
• Michael Hahn, MD, PhD, University of California, San Diego
• Stefanie Hectors, PhD, Weill Cornell Medicine
• Thomas Hope, MD, University of California, San Francisco
• Joseph Ippolito, MD, PhD, Washington University
• Price Jackson, PhD, Peter MacCallum Cancer Centre
• Tamara Jamaspishvili, MD, PhD, State University of New York Upstate Medical University
• Robert Jeraj, PhD, University of Wisconsin
• Stephanie Harmon, PhD, National Cancer Institute
• John Kurhanewicz, PhD, University of California, San Francisco
• Steven Larson, MD, Memorial Sloan Kettering Cancer Center
• Jason Lewis, PhD, Memorial Sloan Kettering Cancer Center
• Raquel Perez-Lopez, PhD, Vall d’Hebron Institute of Oncology
• Martin Pomper, MD, PhD, Johns Hopkins University
• Daniel Thorek, PhD, Johns Hopkins University
• Huihui Ye, MD, University of California, Los Angeles

Molecular Pathology

• Gustavo Ayala, MD, University of Texas Health Science Center
• Tarek Bismar, MD, University of Calgary
• Angelo DeMarzo, MD, PhD, Johns Hopkins University
• Stephen Finn, MBBS, PhD, University of Dublin, Trinity College
• Michael Haffner, MD, Fred Hutchinson Cancer Research Center
• Jiaoti Huang, MD, PhD, Duke University
• Michael Ittmann, MD, PhD, Baylor College of Medicine
• Beatrice Knudsen, MD, PhD, University of Utah
• Massimo Loda, MD, Weill Cornell Medicine
• Tamara Lotan, MD, Johns Hopkins University
• Rohit Mehra, MD, University of Michigan
• David Rickman, PhD, Weill Cornell Medicine
• Antonio Rodriguez-Calero, MD, University of Bern
• Mark Rubin, MD, University of Bern
• Jeffrey Simko, MD, PhD, University of California, San Francisco

Epidemiology / Observational Research

• Burcu Darst, PhD, Fred Hutchinson Cancer Center
• Susan Halabi, PhD, Duke University
• Ashley Holly, PhD, MBA, University of Miami
• Sarah Holt, PhD, Fred Hutchinson Cancer Research Center
• Corinne Joshu, PhD, Johns Hopkins University
• Stacey Kenfield, ScD, University of California, San Francisco
  
• Heather Montie, PhD, Philadelphia College of Osteopathic Medicine
• Lorelei Mucci, ScD, MPH, Harvard School of Public Health
• Kathryn Penney, ScD, Harvard: Dana-Farber Cancer Institute
• Anna Plym, PhD, Karolinska Institutet
• Timothy Rebbeck, PhD, Harvard: Dana-Farber Cancer Institute
• Meir Stampfer, MD, Harvard School of Public Health
• Konrad Stopsack, MD, MPH, Memorial Sloan Kettering Cancer Center
• Bruce Trock, PhD, Johns Hopkins University
• Leanne Woods-Burnham, PhD, City of Hope

Nuclear Medicine

• Jeremie Calais, MD, University of California, Los Angeles
• Johannes Czernin, MD, University of California, Los Angeles
• Andrei Gafita, MD, University of California, Los Angeles
• Michael Hofman, MBBS, Peter MacCallum Cancer Centre